Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma-Reference-Cited by-同舟云学术

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

Published:2017-06 Issue:6 Volume:31 Page:833-843.e5
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Lionakis Michail S.,Dunleavy Kieron,Roschewski Mark,Widemann Brigitte C.,Butman John A.,Schmitz Roland,Yang Yandan,Cole Diane E.,Melani Christopher,Higham Christine S.,Desai Jigar V.,Ceribelli Michele,Chen Lu,Thomas Craig J.,Little Richard F.,Gea-Banacloche Juan,Bhaumik Sucharita,Stetler-Stevenson Maryalice,Pittaluga Stefania,Jaffe Elaine S.,Heiss John,Lucas Nicole,Steinberg Seth M.,Staudt Louis M.,Wilson Wyndham H.

Funder

Intramural Research Program of the NIH

National Cancer Institute

National Institute of Allergy and Infectious Disease

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference57 articles.

1. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma;Abrey;J. Clin. Oncol.,2005

2. Late relapses in primary CNS lymphoma after complete remissions with high-dose methotrexate monotherapy;Ambady;CNS Oncol.,2015

3. Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer;Anders;PLoS One,2013